CPL develops, scales-up and manufactures pharmaceutical products all under one roof, offering formulation services coupled with expert counsel and an emphasis on speed-to-market.

The company keeps projects moving in an efficient and cost-effective manner.

CPL’s product development services (PDS) team is comprised of more than 50 people, including 30 scientists with decades of formulation development and analytical experience. The team supports numerous new drug applications (NDA), abbreviated new drug applications (ANDA), and 505(b)2 pharmaceutical products.

The firm takes on brand new projects, pre-developed projects that need further scale-up or development, and fully developed or approved products.

With a sole focus on non-sterile liquids and semi-solids, CPL’s team possesses unmatched expertise in these dosage forms.

CPL’s development services and capabilities include:

  • Formulation development and product reformulation
  • Process development and optimisation
  • Clinical trial material manufacturing
  • Site/technology transfer management